Manager TitleAgeSince
Chief Executive Officer - 2017-11-21
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 337K
-0.70%+13.34%+75.61%+103.83% 70.85B
-2.35%+2.88%+35.39%+64.72% 55.41B
-1.62%+34.25%+17.43%+491.04% 29.43B
-1.17%+11.92%+53.79%+6.84% 24.12B
0.00%+1.59%-15.06%-13.21% 23.31B
+0.05%+6.12%+46.81%-21.81% 18.37B
+9.77%+20.16%+260.17%+472.38% 16.99B
-0.76%+6.65%+29.96%+618.49% 16.1B
-3.08%-8.34%+37.21%+138.52% 13.12B
Average +0.02%+391.85%+60.15%+206.76% 29.75B
Weighted average by Cap. -0.52%+350.76%+56.14%+166.79%
Logo TheraVet SA
TheraVet SA is specialized in the development of pharmaceutical products for the treatment of osteoarticular diseases in pets. At the end of 2023, the company had a portfolio of 2 products in the clinical development phase: Visco-Vet for the treatment of limping associated with osteoarthritis in dogs and Biocera-Vet for osseointegration and bone remodeling.
Employees
6
  1. Stock Market
  2. Stocks
  3. ALVET Stock